mitoguazone and Central-Nervous-System-Neoplasms

Two studies of mitoguazone (MGBG) have led researchers to believe the drug would be effective in the treatment of newly-diagnosed AIDS lymphoma, especially lymphoma of the central nervous system. ILEX, MGBS's developer, can help people who qualify for new trials but are unable to get to one of the twenty-nine trial centers with expenses. Those who do not qualify for the trials may be eligible to receive the drug on a compassionate-use basis.

Topics: Acquired Immunodeficiency Syndrome; Antineoplastic Agents; Central Nervous System Neoplasms; Clinical Trials as Topic; Humans; Lymphoma, Non-Hodgkin; Mitoguazone; Treatment Failure